Owkin seeks to become cancer ‘drug discovery enterprise’ with $50M investment in MOSAIC project

MOSAIC is a large-scale initiative that combines patient samples and technologies from multiple institutions, hospitals and technology partners, who are joining forces with Owkin to create the largest multimodal, spatial omics atlas in cancer.